Reproducibility of Plasma Metabolome over 1 Year in a Population-Based Cohort of Black Breast Cancer Survivors
A single-timepoint measurement could be useful in evaluating associations between metabolites and breast cancer outcomes.
Authors
- Elisa V. Bandera (ORCID: https://orcid.org/0000-0002-8789-2755)
- Coral Omene (ORCID: https://orcid.org/0000-0001-7824-1478)
- Chi‐Chen Hong (ORCID: https://orcid.org/0000-0001-9212-2264)
- Bo Qin (ORCID: https://orcid.org/0000-0003-2110-6050)
- Tengteng Wang (ORCID: https://orcid.org/0000-0001-9001-186X)
- Kitaw Demissie (ORCID: https://orcid.org/0000-0002-0554-714X)
- Eileen White (ORCID: https://orcid.org/0000-0003-2961-3065)
- Mi‐Hyeon Jang (ORCID: https://orcid.org/0000-0001-6274-3588)
- Xiaoyang Su (ORCID: https://orcid.org/0000-0001-8081-1396)
- Steven C. Moore (ORCID: https://orcid.org/0000-0002-8169-1661)
- Madhir Vyas
Institutions
- Rutgers, The State University of New Jersey (US)
- Roswell Park Comprehensive Cancer Center (US)
- Robert Wood Johnson University Hospital (US)
- SUNY Downstate Health Sciences University (US)
- Ludwig Cancer Research (BE)
- Princeton University (US)
- Johnson University (US)
- Environmental and Occupational Health Sciences Institute (US)
- National Cancer Institute (US)
- Rutgers Cancer Institute (US)
- Division of Cancer Epidemiology and Genetics
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1646
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81